Author:
Ohmachi Ken,Ogura Michinori,Suehiro Youko,Ando Kiyoshi,Uchida Toshiki,Choi Ilseung,Ogawa Yoshiaki,Kobayashi Miki,Fukino Koichi,Yokoi Yuki,Okamura Jun
Publisher
Springer Science and Business Media LLC
Reference29 articles.
1. Shankland KR, Armitage JO, Hancock BW. Non-Hodgkin lymphoma. Lancet. 2012;380:848–57.
2. Nastoupil LJ, Rose AC, Flowers CR. Diffuse large B-cell lymphoma: current treatment approaches. Oncology (Williston Park). 2012;26:488–95.
3. Friedberg JW. Relapsed/refractory diffuse large B-cell lymphoma. Hematol Am Soc Hematol Educ Program. 2011;2011:498–505.
4. Hennessy BT, Hanrahan EO, Daly PA. Non-Hodgkin lymphoma: an update. Lancet Oncol. 2004;5:341–53.
5. Igarashi T, Ogura M, Itoh K, Taniwaki M, Ando K, Kuroda Y, et al. Japanese phase II study Of rituximab maintenance for untreated indolent b-cell non-hodgkin lymphoma with high tumor burden. Int J Hematol. 2016;104:700–708 [Erratum in: Igarashi T, Ogura M, Itoh K, et al. Int J Hematol. 2017;105:109–110].
Cited by
27 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献